BioLineRX Ltd (BLRX) is a publicly traded Healthcare sector company. As of July 8, 2026, BLRX trades at $2.93 with a market cap of $13.74M and a P/E ratio of 0.00. BLRX moved -6.87% today. Year to date, BLRX is +10.00%; over the trailing twelve months it is -26.92%. Its 52-week range spans $2.15 to $22.60. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces BLRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for BLRX, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $2.93 |
| Market Cap | $13.74M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $22.60 |
| 52-Week Low | $2.15 |
| Volume | 207.00K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover BLRX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.